Analysts Set RxSight, Inc. (NASDAQ:RXST) PT at $49.63

RxSight, Inc. (NASDAQ:RXST – Get Free Report) has been given a consensus recommendation of “Buy” by the six analysts that are currently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock in the […]

Related Keywords

United States ,Eric Weinberg ,Stifel Nicolaus ,Shelleyb Thunen ,Nasdaq ,Jpmorgan Chase Co ,Needham Company ,Securities Exchange Commission ,Vanguard Group Inc ,Artisan Partners Limited Partnership ,Allspring Global Investments Holdings ,Rxsight Inc ,Lisanti Capital Growth ,Rxsight Company Profile ,Get Free Report ,Exchange Commission ,Capital Growth ,Global Investments Holdings ,Partners Limited Partnership ,Get Free ,Rxsight Daily ,Rxsight ,Nasdaq Rxst ,Rxst ,Medical ,Ratings ,Consensus ,